Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.51 |
| ▸ | CNR2 | P34972 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.40 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.39 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.39 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2524076 | 1.00 | CNR1 (0.51) | CNR1CNR2ALDH1A1USP2LPAR1 | |
| Pyrophosphoric Acid SCHEMBL8080994 | 0.89 | LPAR3 (0.50) | CNR1CNR2ALDH1A1LPAR1LPAR3 | |
| SCHEMBL7784745 | 0.87 | USP2 (0.50) | CNR1CNR2ALDH1A1USP2LPAR1 | |
| SCHEMBL4565926 | 0.86 | LPAR1 (0.51) | CNR1CNR2ALDH1A1USP2LPAR1 | |
| SCHEMBL10564674 | 0.85 | USP2 (0.53) | CNR1CNR2ALDH1A1USP2LPAR1 | |
| SCHEMBL28854928 | 0.85 | USP2 (0.53) | CNR1CNR2ALDH1A1USP2LPAR1 | |
| SCHEMBL24470522 | 0.85 | LPAR1 (0.54) | USP2LPAR1LPAR3LPAR2DNM1 | |
| SCHEMBL11306605 | 0.85 | LPAR1 (0.54) | USP2LPAR1LPAR3LPAR2DNM1 | |
| SCHEMBL11299369 | 0.85 | LPAR1 (0.54) | USP2LPAR1LPAR3LPAR2DNM1 | |
| SCHEMBL102699 | 0.85 | LPAR1 (0.54) | USP2LPAR1LPAR3LPAR2DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5463092-A | Viricides | VESTAR, INC. (US) | 1995-10-31 | — | — | US | claimed |
| EP-2277849-B1 | PROCESS FOR THE PREPARATION OF 1-ALKYL GLYCEROL ETHERS | SCHUELKE & MAYR GMBH (DE) | 2019-08-07 | — | — | EP | disclosed |
| US-9334235-B2 | Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging | PHENOMENOME DISCOVERIES INC. (CA) | 2016-05-10 | — | — | US | disclosed |
| US-8877983-B2 | Process for the preparation of 1-alkyl glycerol ethers | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2014-11-04 | — | — | US | disclosed |
| US-20130116312-A2 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING | PHENOMENOME DISCOVERIES INC. (CA) | 2013-05-09 | — | — | US | disclosed |
| US-20120035250-A1 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING | PHENOMENOME DISCOVERIES INC. (CA) | 2012-02-09 | — | — | US | disclosed |
| EP-2277849-A1 | Process for the preparation of 1-alkyl glycerol ethers | L'AIR LIQUIDE, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) | 2011-01-26 | — | — | EP | disclosed |
| US-20110009676-A1 | PROCESS FOR THE PREPARATION OF 1-ALKYL GLYCEROL ETHERS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGE (FR) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035250-A1 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING | PHOSPHO1, SGMS2, MBOAT1 | CNR1 1522/4885CNR2 899/4885ALDH1A1 1960/4885 |
| US-20110009676-A1 | PROCESS FOR THE PREPARATION OF 1-ALKYL GLYCEROL ETHERS | GK, UGCG, DEGS1 | CNR1 491/4885CNR2 559/4885ALDH1A1 546/4885 |
| US-20130116312-A2 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING | PHOSPHO1, SGMS2, MBOAT1 | CNR1 1522/4885CNR2 899/4885ALDH1A1 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.